Unique centralized service helps increase the supply of lungs for transplant, addressing a critical unmet need SILVER SPRING, Md. & JACKSONVILLE, Fla. / Oct 23, 2024 / Business Wire / United Therapeutics Corporation (Nasdaq: UTHR ), a public benefit corporation, and its subsidiary Lung Bioengineering Inc. ( LBE ) announced that the 500 th lung transplant utilizing LBE’s centralized ex vivo lung perfusion ( EVLP ) service was... Read More